Product NDC: | 55390-059 |
Proprietary Name: | Orphenadrine citrate |
Non Proprietary Name: | Orphenadrine citrate |
Active Ingredient(s): | 60 mg/2mL & nbsp; Orphenadrine citrate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-059 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040463 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030428 |
Package NDC: | 55390-059-10 |
Package Description: | 10 VIAL in 1 BOX (55390-059-10) > 2 mL in 1 VIAL |
NDC Code | 55390-059-10 |
Proprietary Name | Orphenadrine citrate |
Package Description | 10 VIAL in 1 BOX (55390-059-10) > 2 mL in 1 VIAL |
Product NDC | 55390-059 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Orphenadrine citrate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20030428 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | ORPHENADRINE CITRATE |
Strength Number | 60 |
Strength Unit | mg/2mL |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |